UniProt ID | NAB2_HUMAN | |
---|---|---|
UniProt AC | Q15742 | |
Protein Name | NGFI-A-binding protein 2 | |
Gene Name | NAB2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 525 | |
Subcellular Localization | Nucleus. Isoform 2 is not localized to the nucleus.. | |
Protein Description | Acts as a transcriptional repressor for zinc finger transcription factors EGR1 and EGR2. Isoform 2 lacks repression ability (By similarity).. | |
Protein Sequence | MHRAPSPTAEQPPGGGDSARRTLQPRLKPSARAMALPRTLGELQLYRVLQRANLLSYYETFIQQGGDDVQQLCEAGEEEFLEIMALVGMATKPLHVRRLQKALREWATNPGLFSQPVPAVPVSSIPLFKISETAGTRKGSMSNGHGSPGEKAGSARSFSPKSPLELGEKLSPLPGGPGAGDPRIWPGRSTPESDVGAGGEEEAGSPPFSPPAGGGVPEGTGAGGLAAGGTGGGPDRLEPEMVRMVVESVERIFRSFPRGDAGEVTSLLKLNKKLARSVGHIFEMDDNDSQKEEEIRKYSIIYGRFDSKRREGKQLSLHELTINEAAAQFCMRDNTLLLRRVELFSLSRQVARESTYLSSLKGSRLHPEELGGPPLKKLKQEVGEQSHPEIQQPPPGPESYVPPYRPSLEEDSASLSGESLDGHLQAVGSCPRLTPPPADLPLALPAHGLWSRHILQQTLMDEGLRLARLVSHDRVGRLSPCVPAKPPLAEFEEGLLDRCPAPGPHPALVEGRRSSVKVEAEASRQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Phosphorylation | --MHRAPSPTAEQPP --CCCCCCCCCCCCC | 33.62 | 19664994 | |
8 | Phosphorylation | MHRAPSPTAEQPPGG CCCCCCCCCCCCCCC | 47.35 | 30266825 | |
18 | Phosphorylation | QPPGGGDSARRTLQP CCCCCCCHHHHHCCC | 27.27 | 23090842 | |
123 | O-linked_Glycosylation | PVPAVPVSSIPLFKI CCCCCCCCCCCEEEE | 19.24 | 29351928 | |
131 | Phosphorylation | SIPLFKISETAGTRK CCCEEEEECCCCCCC | 29.50 | 27251275 | |
140 | Phosphorylation | TAGTRKGSMSNGHGS CCCCCCCCCCCCCCC | 23.28 | 29396449 | |
142 | Phosphorylation | GTRKGSMSNGHGSPG CCCCCCCCCCCCCCC | 41.16 | 30576142 | |
147 | Phosphorylation | SMSNGHGSPGEKAGS CCCCCCCCCCCCCCC | 24.85 | 25849741 | |
154 | Phosphorylation | SPGEKAGSARSFSPK CCCCCCCCCCCCCCC | 25.93 | 22210691 | |
157 | Phosphorylation | EKAGSARSFSPKSPL CCCCCCCCCCCCCCC | 29.77 | 23927012 | |
159 | Phosphorylation | AGSARSFSPKSPLEL CCCCCCCCCCCCCHH | 32.44 | 23927012 | |
162 | Phosphorylation | ARSFSPKSPLELGEK CCCCCCCCCCHHCCC | 37.79 | 29255136 | |
169 | Ubiquitination | SPLELGEKLSPLPGG CCCHHCCCCCCCCCC | 53.09 | 29967540 | |
169 | Sumoylation | SPLELGEKLSPLPGG CCCHHCCCCCCCCCC | 53.09 | - | |
171 | Phosphorylation | LELGEKLSPLPGGPG CHHCCCCCCCCCCCC | 35.14 | 29255136 | |
189 | Phosphorylation | PRIWPGRSTPESDVG CCCCCCCCCCHHHCC | 54.98 | 25850435 | |
190 | Phosphorylation | RIWPGRSTPESDVGA CCCCCCCCCHHHCCC | 29.70 | 25850435 | |
193 | Phosphorylation | PGRSTPESDVGAGGE CCCCCCHHHCCCCCC | 38.51 | 25850435 | |
205 | Phosphorylation | GGEEEAGSPPFSPPA CCCCCCCCCCCCCCC | 36.13 | 29496963 | |
209 | Phosphorylation | EAGSPPFSPPAGGGV CCCCCCCCCCCCCCC | 35.43 | 25850435 | |
220 | Phosphorylation | GGGVPEGTGAGGLAA CCCCCCCCCCCCCCC | 23.38 | 25850435 | |
230 | Phosphorylation | GGLAAGGTGGGPDRL CCCCCCCCCCCCCCC | 31.56 | 25850435 | |
266 | Phosphorylation | GDAGEVTSLLKLNKK CCHHHHHHHHHHHHH | 36.56 | 24719451 | |
269 | Ubiquitination | GEVTSLLKLNKKLAR HHHHHHHHHHHHHHH | 56.14 | 29967540 | |
277 | Phosphorylation | LNKKLARSVGHIFEM HHHHHHHHHCCCEEC | 27.18 | 23401153 | |
289 | Phosphorylation | FEMDDNDSQKEEEIR EECCCCCHHHHHHHH | 49.78 | 29507054 | |
316 | Phosphorylation | RREGKQLSLHELTIN CCCCCCCEEEEEEHH | 25.78 | 24043423 | |
321 | Phosphorylation | QLSLHELTINEAAAQ CCEEEEEEHHHHHHH | 20.83 | 24043423 | |
358 | Phosphorylation | ARESTYLSSLKGSRL HHHHHHHHCCCCCCC | 24.18 | 24719451 | |
361 | Ubiquitination | STYLSSLKGSRLHPE HHHHHCCCCCCCCHH | 57.71 | 27667366 | |
361 | Sumoylation | STYLSSLKGSRLHPE HHHHHCCCCCCCCHH | 57.71 | - | |
361 | Sumoylation | STYLSSLKGSRLHPE HHHHHCCCCCCCCHH | 57.71 | - | |
376 | Ubiquitination | ELGGPPLKKLKQEVG HHCCCCHHHHHHHHH | 62.93 | 29967540 | |
376 | Acetylation | ELGGPPLKKLKQEVG HHCCCCHHHHHHHHH | 62.93 | 30590651 | |
379 | Sumoylation | GPPLKKLKQEVGEQS CCCHHHHHHHHHHCC | 53.98 | 21836637 | |
407 (in isoform 3) | Phosphorylation | - | 39.14 | 27732954 | |
412 (in isoform 3) | Phosphorylation | - | 24.04 | 27732954 | |
414 (in isoform 3) | Phosphorylation | - | 27.33 | 27732954 | |
416 (in isoform 3) | Phosphorylation | - | 37.71 | 27732954 | |
419 (in isoform 3) | Phosphorylation | - | 34.97 | 27732954 | |
434 | Phosphorylation | VGSCPRLTPPPADLP CCCCCCCCCCCCCCC | 34.72 | 30266825 | |
471 | Phosphorylation | LRLARLVSHDRVGRL HHHHHHHHCCCCCCC | 25.02 | 24719451 | |
479 | Phosphorylation | HDRVGRLSPCVPAKP CCCCCCCCCCCCCCC | 18.20 | 29255136 | |
514 | Phosphorylation | ALVEGRRSSVKVEAE HHHCCCCCCCCCCHH | 37.82 | 26699800 | |
515 | Phosphorylation | LVEGRRSSVKVEAEA HHCCCCCCCCCCHHH | 24.93 | 27273156 | |
517 | Sumoylation | EGRRSSVKVEAEASR CCCCCCCCCCHHHHC | 35.98 | 21836637 | |
517 | Sumoylation | EGRRSSVKVEAEASR CCCCCCCCCCHHHHC | 35.98 | - | |
523 | Phosphorylation | VKVEAEASRQ----- CCCCHHHHCC----- | 23.79 | 27486199 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NAB2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NAB2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6; SER-162 AND SER-479,AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-171, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-159 AND SER-162, ANDMASS SPECTROMETRY. |